← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

TFX logoTeleflex Incorporated(TFX)Earnings, Financials & Key Ratios

TFX•NYSE
$123.23
$5.45B mkt cap·Price updated May 6, 2026
SectorHealthcareIndustryMedical InstrumentsSub-IndustrySurgical and interventional devices
AboutTeleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.Show more
  • Revenue$1.99B-34.6%
  • EBITDA$434M+1.9%
  • Net Income-$906M-1399.8%
  • EPS (Diluted)-20.25-1468.2%
  • Gross Margin56.24%+0.7%
  • EBITDA Margin21.76%+55.8%
  • Operating Margin12.84%+159.0%
  • Net Margin-45.45%-2087.7%
  • ROE-24.47%-1630.9%
  • ROIC3.43%+79.8%
  • Debt/Equity0.87+112.6%
  • Interest Coverage1.24-34.6%
Technical→

TFX Key Insights

Teleflex Incorporated (TFX) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Share count reduced 5.0% through buybacks

✗Weaknesses

  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

TFX Price & Volume

Teleflex Incorporated (TFX) stock price & volume — 10-year historical chart

Loading chart...

TFX Growth Metrics

Teleflex Incorporated (TFX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years0.97%
5 Years-4.72%
3 Years-10.62%
TTM-2.75%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-1399.8%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-1547.18%

Return on Capital

10 Years6.94%
5 Years6.34%
3 Years4.65%
Last Year4.05%

TFX Recent Earnings

Teleflex Incorporated (TFX) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 6/12 qtrs (50%)
Q1 2026Latest
Feb 26, 2026
EPS
$1.93
Est $3.73
-48.3%
Revenue
$569M
Est $919M
-38.1%
Q4 2025
Nov 6, 2025
EPS
$3.67
Est $3.38
+8.6%
Revenue
$913M
Est $915M
-0.2%
Q3 2025
Jul 31, 2025
EPS
$3.73
Est $3.36
+11.0%
Revenue
$781M
Est $893M
-12.5%
Q2 2025
May 1, 2025
EPS
$2.91
Est $2.88
+1.0%
Revenue
$701M
Est $766M
-8.5%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q1 2026LatestFeb 26, 2026
$1.93vs $3.73-48.3%
$569Mvs $919M-38.1%
Q4 2025Nov 6, 2025
$3.67vs $3.38+8.6%
$913Mvs $915M-0.2%
Q3 2025Jul 31, 2025
$3.73vs $3.36+11.0%
$781Mvs $893M-12.5%
Q2 2025May 1, 2025
$2.91vs $2.88+1.0%
$701Mvs $766M-8.5%
Based on last 12 quarters of dataView full earnings history →

TFX Peer Comparison

Teleflex Incorporated (TFX) competitors in Surgical and interventional devices — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
ICU logoICUSeaStar Medical Holding CorporationDirect Competitor29.11M4.87-0.73-15.51%-119.2%
UTMD logoUTMDUtah Medical Products, Inc.Direct Competitor206.35M64.4118.51-5.83%29.3%9.56%0.00
ATRC logoATRCAtriCure, Inc.Direct Competitor1.42B28.01-116.7114.88%-0.83%-0.95%0.18
NVCR logoNVCRNovoCure LimitedDirect Competitor1.88B16.50-13.528.28%-25.66%-50.82%0.85
ANGO logoANGOAngioDynamics, Inc.Direct Competitor459.4M11.05-13.31-3.76%-9.02%-15.71%
MMSI logoMMSIMerit Medical Systems, Inc.Direct Competitor3.68B61.6328.9311.66%9.03%8.95%0.57
BDX logoBDXBecton, Dickinson and CompanyProduct Competitor52.45B144.7624.838.23%8.01%6.93%0.76
BAX logoBAXBaxter International Inc.Product Competitor8.77B16.98-9.705.72%-9.7%-16.5%1.64

Compare TFX vs Peers

Teleflex Incorporated (TFX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ICU

Most directly comparable listed peer for TFX.

Scale Benchmark

vs ABT

Larger-name benchmark to compare TFX against a more recognizable public peer.

Peer Set

Compare Top 5

vs ICU, UTMD, ATRC, NVCR

TFX Income Statement

Teleflex Incorporated (TFX) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue2.15B2.45B2.6B2.54B2.81B2.79B2.97B3.05B1.99B
Revenue Growth %14.9%14.07%6%-2.24%10.74%-0.66%6.57%2.45%-34.61%
Cost of Goods Sold974.5M1.06B1.19B1.21B1.26B1.26B1.33B1.34B871.96M
COGS % of Revenue45.4%43.45%45.71%47.78%44.85%45.14%44.63%44.13%43.76%
Gross Profit
1.17B▲ 0%
1.38B▲ 18.1%
1.41B▲ 1.8%
1.32B▼ 6.0%
1.55B▲ 17.0%
1.53B▼ 1.2%
1.65B▲ 7.6%
1.7B▲ 3.4%
1.12B▼ 34.2%
Gross Margin %54.6%56.55%54.29%52.22%55.15%54.86%55.37%55.87%56.24%
Gross Profit Growth %17.63%18.15%1.77%-5.97%16.96%-1.19%7.57%3.38%-34.18%
Operating Expenses784.73M984.9M981.75M901.81M921.51M1.03B1.14B1.55B864.95M
OpEx % of Revenue36.56%40.23%37.83%35.54%32.8%36.95%38.35%50.92%43.41%
Selling, General & Admin699.96M878.69M851.77M743.57M860.09M863.75M929.87M995.27M720.17M
SG&A % of Revenue32.61%35.89%32.82%29.31%30.61%30.95%31.26%32.66%36.14%
Research & Development84.77M106.21M113.86M119.75M130.84M153.82M154.35M161.67M144.78M
R&D % of Revenue3.95%4.34%4.39%4.72%4.66%5.51%5.19%5.31%7.27%
Other Operating Expenses0016.13M38.49M-69.42M13.79M56.4M394.72M0
Operating Income
372.28M▲ 0%
321.7M▼ 13.6%
427.25M▲ 32.8%
423.07M▼ 1.0%
628.1M▲ 48.5%
499.73M▼ 20.4%
506.31M▲ 1.3%
151.01M▼ 70.2%
255.8M▲ 69.4%
Operating Margin %17.35%13.14%16.46%16.67%22.36%17.9%17.02%4.96%12.84%
Operating Income Growth %16.54%-13.59%32.81%-0.98%48.46%-20.44%1.32%-70.17%69.39%
EBITDA527.54M531.68M641.32M650.32M865.46M730.32M748.43M425.61M433.54M
EBITDA Margin %24.58%21.72%24.71%25.63%30.8%26.17%25.16%13.97%21.76%
EBITDA Growth %20.62%0.79%20.62%1.4%33.08%-15.62%2.48%-43.13%1.86%
D&A (Non-Cash Add-back)155.26M209.98M214.06M227.25M237.36M230.59M242.12M274.6M177.74M
EBIT367.46M322.65M420.17M424.23M616.44M500.18M519.09M159.02M124.78M
Net Interest Income-81.78M-102.08M-78.53M-65.34M-55.64M-53.35M-72.3M-75.53M-93.82M
Interest Income771K944K1.74M1.16M1.33M912K12.78M8.01M6.4M
Interest Expense82.55M103.02M80.27M66.49M56.97M54.26M85.08M83.54M100.22M
Other Income/Expense-87.37M23.2M-87.35M-65.34M-68.63M-53.81M-72.3M-75.53M-231.25M
Pretax Income
284.91M▲ 0%
219.63M▼ 22.9%
339.9M▲ 54.8%
357.73M▲ 5.2%
559.47M▲ 56.4%
445.92M▼ 20.3%
434.01M▼ 2.7%
75.48M▼ 82.6%
24.55M▼ 67.5%
Pretax Margin %13.27%8.97%13.1%14.1%19.91%15.98%14.59%2.48%1.23%
Income Tax129.65M23.2M-122.08M21.93M74.35M83M76.44M5.32M-33.98M
Effective Tax Rate %45.5%10.56%-35.92%6.13%13.29%18.61%17.61%7.04%-138.38%
Net Income
152.53M▲ 0%
200.8M▲ 31.6%
461.47M▲ 129.8%
335.32M▼ 27.3%
485.37M▲ 44.7%
363.14M▼ 25.2%
356.33M▼ 1.9%
69.67M▼ 80.4%
-905.64M▼ 1399.8%
Net Margin %7.11%8.2%17.78%13.22%17.28%13.01%11.98%2.29%-45.45%
Net Income Growth %-35.74%31.65%129.81%-27.34%44.75%-25.18%-1.88%-80.45%-1399.81%
Net Income (Continuing)155.26M196.43M461.98M335.8M485.12M362.92M357.57M70.16M58.53M
Discontinued Operations04.37M-515K-477K255K223K-1.24M-487K-964.17M
Minority Interest000000000
EPS (Diluted)
3.27▲ 0%
4.29▲ 31.2%
9.80▲ 128.4%
7.09▼ 27.7%
10.23▲ 44.3%
7.68▼ 24.9%
7.53▼ 2.0%
1.48▼ 80.3%
-20.25▼ 1468.2%
EPS Growth %-34.34%31.19%128.44%-27.65%44.29%-24.93%-1.95%-80.35%-1468.24%
EPS (Basic)3.394.399.997.2110.387.747.581.49-20.30
Diluted Shares Outstanding46.66M46.8M47.09M47.29M47.43M47.31M47.3M47.09M44.72M
Basic Shares Outstanding45M45.69M46.2M46.49M46.77M46.9M46.98M46.84M44.62M
Dividend Payout Ratio40.15%30.96%13.61%18.85%13.11%17.57%17.93%91.2%-

TFX Balance Sheet

Teleflex Incorporated (TFX) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets1.13B1.24B1.31B1.42B1.43B1.41B1.41B1.47B1.94B
Cash & Short-Term Investments333.56M357.16M301.08M375.88M445.08M292.03M222.85M306.16M393.26M
Cash Only333.56M357.16M301.08M375.88M445.08M292.03M222.85M290.19M393.26M
Short-Term Investments000000015.97M0
Accounts Receivable345.88M366.29M418.67M395.07M383.57M408.83M443.47M459.5M345.58M
Days Sales Outstanding58.8254.6158.8856.8449.8353.4754.4255.0463.3
Inventory395.74M427.78M476.56M513.2M477.64M578.51M626.22M600.13M404.39M
Days Inventory Outstanding148.23146.76146.62154.52138.37167.59172.17162.9169.28
Other Current Assets47.88M72.48M97.94M115.44M117.28M125.08M107.47M101.88M775.53M
Total Non-Current Assets5.05B5.04B5B5.73B5.44B5.52B6.13B5.63B5.01B
Property, Plant & Equipment383M432.77M543.88M574.55M573.41M578.42M603.43M611.76M590.1M
Fixed Asset Turnover5.60x5.66x4.77x4.42x4.90x4.83x4.93x4.98x3.38x
Goodwill2.24B2.25B2.25B2.59B2.5B2.54B2.91B2.63B2.31B
Intangible Assets2.38B2.33B2.16B2.52B2.29B2.31B2.5B2.27B1.52B
Long-Term Investments3.3M2.7M00011.91M0011.19M
Other Non-Current Assets43.24M32.28M52.45M41.8M69.1M77.45M98.94M102.62M565.82M
Total Assets
6.18B▲ 0%
6.28B▲ 1.6%
6.31B▲ 0.5%
7.15B▲ 13.4%
6.87B▼ 3.9%
6.93B▲ 0.8%
7.53B▲ 8.7%
7.1B▼ 5.8%
6.95B▼ 2.1%
Asset Turnover0.35x0.39x0.41x0.35x0.41x0.40x0.39x0.43x0.29x
Asset Growth %58.86%1.56%0.51%13.36%-3.93%0.82%8.73%-5.77%-2.12%
Total Current Liabilities483.88M582.46M563.05M540.03M680.12M581.49M606.75M649.36M762.03M
Accounts Payable92.03M106.71M102.92M102.52M118.24M126.81M132.25M141.03M130.2M
Days Payables Outstanding34.4736.6131.6630.8734.2536.7436.3638.2854.5
Short-Term Debt86.63M86.63M50M100.5M110M87.5M87.5M100M100M
Deferred Revenue (Current)221.95M5.94M0000000
Other Current Liabilities186.29M278.51M181.49M53.87M55.63M63.38M46.55M68.54M388.27M
Current Ratio2.33x2.12x2.32x2.63x2.10x2.43x2.32x2.27x2.54x
Quick Ratio1.51x1.39x1.47x1.68x1.40x1.43x1.29x1.34x2.01x
Cash Conversion Cycle172.58164.75173.84180.48153.95184.32190.23179.66178.08
Total Non-Current Liabilities3.27B3.16B2.77B3.28B2.44B2.32B2.48B2.17B3.06B
Long-Term Debt2.16B2.07B1.86B2.38B1.74B1.62B1.73B1.56B2.54B
Capital Lease Obligations00101.37M86.1M116.03M120.44M111.3M99.15M84.21M
Deferred Tax Liabilities603.68M608.22M439.56M484.68M370.12M388.89M456.08M391.07M183.75M
Other Non-Current Liabilities500.48M475.14M367.57M327.41M210.6M191.26M189.86M124.32M251.04M
Total Liabilities3.75B3.74B3.33B3.82B3.12B2.91B3.09B2.82B3.82B
Total Debt2.25B2.16B2.01B2.56B1.97B1.83B1.93B1.76B2.73B
Net Debt1.92B1.8B1.71B2.19B1.52B1.54B1.7B1.46B2.33B
Debt / Equity0.93x0.85x0.67x0.77x0.52x0.46x0.43x0.41x0.87x
Debt / EBITDA4.26x4.06x3.13x3.94x2.27x2.51x2.57x4.12x6.29x
Net Debt / EBITDA3.63x3.39x2.67x3.37x1.76x2.11x2.28x3.44x5.38x
Interest Coverage4.45x3.13x5.23x6.38x10.82x9.22x6.10x1.90x1.24x
Total Equity
2.43B▲ 0%
2.54B▲ 4.5%
2.98B▲ 17.3%
3.34B▲ 12.0%
3.75B▲ 12.5%
4.02B▲ 7.1%
4.44B▲ 10.4%
4.28B▼ 3.7%
3.12B▼ 27.0%
Equity Growth %13.61%4.5%17.3%11.99%12.54%7.12%10.42%-3.67%-26.96%
Book Value per Share52.0954.2763.2770.5679.1785.0193.8890.8469.87
Total Shareholders' Equity2.43B2.54B2.98B3.34B3.75B4.02B4.44B4.28B3.12B
Common Stock46.87M47.25M47.54M47.81M47.93M47.96M48.05M48.1M48.2M
Retained Earnings2.29B2.43B2.82B3.1B3.52B3.82B4.11B4.12B3.15B
Treasury Stock-228.86M-168.54M-165.72M-162.59M-157.27M-154.89M-152.1M-350.34M-649.53M
Accumulated OCI-265.09M-341.08M-344.39M-297.3M-346.96M-403.52M-314.4M-316.67M-239.47M
Minority Interest000000000

TFX Cash Flow Statement

Teleflex Incorporated (TFX) cash flow — operating, investing & free cash flow history

Line itemDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations419.88M437.38M439.52M436.41M651.42M342.14M510.64M635.74M340.68M
Operating CF Margin %19.56%17.86%16.93%17.2%23.19%12.26%17.17%20.86%17.1%
Operating CF Growth %2.79%4.17%0.49%-0.71%49.27%-47.48%49.25%24.5%-46.41%
Net Income152.53M200.8M461.47M335.32M485.37M363.14M356.33M69.67M58.53M
Depreciation & Amortization155.26M209.98M214.06M227.25M237.36M230.59M242.12M274.6M177.74M
Stock-Based Compensation19.41M22.44M26.94M20.74M22.94M27.22M31.46M31.35M0
Deferred Taxes-41.82M-6.1M-168.59M-32.67M-110.24M-13.01M-13.05M0-100.97M
Other Non-Cash Items2.53M54.55M20.15M-136.51M-111.36M-25.84M5.54M261.94M286.46M
Working Capital Changes131.97M-44.3M-114.5M22.28M127.34M-239.96M-111.77M-1.82M-81.09M
Change in Receivables-11.04M-23.41M-59.79M44.75M-600K-38.46M-15.76M-27.95M-85.53M
Change in Inventory-22.36M-37.2M-53.17M-5.5M-11.14M-110.69M-41.07M1.72M84.04M
Change in Payables39M52.05M5M-3.68M94.02M-24.79M-31.26M9.66M-8.28M
Cash from Investing-1.83B-196.39M-73.48M-837.78M156.74M-257.94M-621.23M-99.36M-849.19M
Capital Expenditures-70.9M-80.8M-102.69M-90.69M-71.62M-79.19M-91.44M-126.43M-95.24M
CapEx % of Revenue3.3%3.3%3.96%3.57%2.55%2.84%3.07%4.15%4.78%
Acquisitions-1.76B-117.15M10.88M-766.43M220.32M-186M-588.92M-120K-825.14M
Investments---------
Other Investing6.33M1.55M18.33M19.34M19.15M22.24M63.13M27.2M76.19M
Cash from Financing1.14B-206.43M-418.84M455.16M-715.82M-217.51M38.54M-421.93M611.54M
Debt Issued (Net)1.22B-93.5M-253.5M575M-634.5M-145.45M101.25M-161.5M982.04M
Equity Issued (Net)000011.1M00-200M-300M
Dividends Paid-61.24M-62.16M-62.83M-63.22M-63.65M-63.79M-63.9M-63.54M-60.27M
Share Repurchases00-21.21M00-4.31M0-200M-300M
Other Financing-21.43M-50.77M-102.51M-56.62M-28.77M-8.27M1.19M3.12M-10.23M
Net Change in Cash
-210.23M▲ 0%
23.6M▲ 111.2%
-56.08M▼ 337.6%
74.8M▲ 233.4%
69.2M▼ 7.5%
-153.05M▼ 321.2%
-69.19M▲ 54.8%
104.8M▲ 251.5%
73.68M▼ 29.7%
Free Cash Flow
348.98M▲ 0%
356.58M▲ 2.2%
336.83M▼ 5.5%
345.71M▲ 2.6%
579.8M▲ 67.7%
262.95M▼ 54.6%
419.2M▲ 59.4%
509.31M▲ 21.5%
245.44M▼ 51.8%
FCF Margin %16.26%14.56%12.98%13.63%20.64%9.42%14.09%16.71%12.32%
FCF Growth %-1.79%2.18%-5.54%2.64%67.71%-54.65%59.42%21.5%-51.81%
FCF per Share7.487.627.157.3112.235.568.8610.815.49
FCF Conversion (FCF/Net Income)2.75x2.18x0.95x1.30x1.34x0.94x1.43x9.12x-0.38x
Interest Paid74.26M101.79M0073.6M70.92M100.22M98.38M0
Taxes Paid49.14M65.61M00108.61M162.05M114.21M164.9M0

TFX Key Ratios

Teleflex Incorporated (TFX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)11.44%6.68%8.08%16.72%10.62%13.69%9.34%8.42%1.6%-24.47%
Return on Invested Capital (ROIC)8.93%8.01%5.55%7.1%6.21%8.72%6.92%6.49%1.91%3.43%
Gross Margin53.33%54.6%56.55%54.29%52.22%55.15%54.86%55.37%55.87%56.24%
Net Margin12.71%7.11%8.2%17.78%13.22%17.28%13.01%11.98%2.29%-45.45%
Debt / Equity0.48x0.93x0.85x0.67x0.77x0.52x0.46x0.43x0.41x0.87x
Interest Coverage5.47x4.45x3.13x5.23x6.38x10.82x9.22x6.10x1.90x1.24x
FCF Conversion1.72x2.75x2.18x0.95x1.30x1.34x0.94x1.43x9.12x-0.38x
Revenue Growth3.22%14.9%14.07%6%-2.24%10.74%-0.66%6.57%2.45%-34.61%

TFX SEC Filings & Documents

Teleflex Incorporated (TFX) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 30, 2026·SEC

Material company update

Mar 27, 2026·SEC

Material company update

Mar 17, 2026·SEC

10-K Annual Reports

4
FY 2026

Feb 27, 2026·SEC

FY 2025

Feb 28, 2025·SEC

FY 2024

Feb 23, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 6, 2025·SEC

FY 2025

Jul 31, 2025·SEC

FY 2025

May 1, 2025·SEC

TFX Frequently Asked Questions

Teleflex Incorporated (TFX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Teleflex Incorporated (TFX) reported $2.96B in revenue for fiscal year 2025. This represents a 218% increase from $931.2M in 1996.

Teleflex Incorporated (TFX) saw revenue decline by 34.6% over the past year.

Teleflex Incorporated (TFX) reported a net loss of $905.6M for fiscal year 2025.

Dividend & Returns

Yes, Teleflex Incorporated (TFX) pays a dividend with a yield of 1.09%. This makes it attractive for income-focused investors.

Teleflex Incorporated (TFX) has a return on equity (ROE) of -24.5%. Negative ROE indicates the company is unprofitable.

Teleflex Incorporated (TFX) generated $245.4M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More TFX

Teleflex Incorporated (TFX) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.